Page last updated: 2024-11-05

thiotepa and Arrhythmia

thiotepa has been researched along with Arrhythmia in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research Excerpts

ExcerptRelevanceReference
"There were three atrial arrhythmias, two ventricular arrhythmias, and four atrioventricular (AV)-block episodes."1.31Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation. ( Adachi, I; Ando, M; Kawahigashi, N; Kobayashi, Y; Mineishi, S; Narabayashi, M; Sawada, J; Takaue, Y; Takeyama, K; Tanosaki, R; Tobinai, K; Togitani, K; Watanabe, T; Yokozawa, T, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, M1
Yokozawa, T1
Sawada, J1
Takaue, Y1
Togitani, K1
Kawahigashi, N1
Narabayashi, M1
Takeyama, K1
Tanosaki, R1
Mineishi, S1
Kobayashi, Y1
Watanabe, T1
Adachi, I1
Tobinai, K1

Other Studies

1 other study available for thiotepa and Arrhythmia

ArticleYear
Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation.
    Bone marrow transplantation, 2000, Volume: 25, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Breast Neoplasms; Combi

2000